Functional elements of the steroid hormone-responsive promoter of mouse mammary tumor virus. by M G Toohey et al.
JOURNAL OF VIROLOGY, Sept. 1990, p. 4477-4488
0022-538X/90/094477-12$02.00/0
Copyright C) 1990, American Society for Microbiology
Functional Elements of the Steroid Hormone-Responsive Promoter
of Mouse Mammary Tumor Virus
MARK G. TOOHEY,t JAE WOON LEE, MIKE HUANG, AND DAVID 0. PETERSON*
Department of Biochemistry and Biophysics, Texas A&M University, College Station, Texas 77843
Received 14 September 1989/Accepted 31 May 1990
Transcription from the promoter of mouse mammary tumor virus is subject to induction by several classes
of steroid hormones as well as to repression by a negative regulatory element present in the long terminal
repeats of proviral DNA. In order to characterize the functional elements of the promoter that in some way
must respond to these regulatory signals, a number of promoter mutations were constructed, including a set
of linker-scanning mutations across the entire promoter region. Analysis of these mutated promoters with a
transient-transfection assay defined at least three mutation-sensitive promoter elements that are required for
both basal and hormone-induced transcription. One mutation-sensitive region contains a TATA element
located at approximately position -30 with respect to the start of transcription. A second mutation-sensitive
region contains two 10-base-pair direct repeats located between positions -60 and -38, within which are
embedded three copies of octamer-related sequences; complete disruption of this region of the promoter leads
to a more severe decrease in transcription than do any of the linker-scanning mutations, suggesting that the
repeated sequences may be at least partially functionally redundant. Gel electrophoresis mobility shift assays
were used to demonstrate specffic binding of a nuclear protein to this region of the promoter. A third mutation-
sensitive region contains a binding site for nuclear factor 1 (NF-1) located between positions -77 and -63. Site-
directed mutations in the NF-1-binding site which increase the apparent affinity of NF-1 for the promoter in
vitro do not decrease the hormone dependence of transcription, suggesting that transcriptional activation
mediated by steroid hormone-receptor complexes cannot be explained by facilitation or stabilization of the
interaction of promoter sequences with NF-1 and consistent with the idea that binding of NF-1 is not rate
determining in transcription from the mouse mammary tumor virus promoter. None of the promoter mutations
functionally separates basal from glucocorticoid-induced transcription, suggesting that hormone induction does
not make the promoter independent of any of the DNA-binding factors required for its basal activity.
Transcription of the proviral DNA of mouse mammary
tumor virus (MMTV) is positively regulated by several
classes of steroid hormones, including glucocorticoids (58,
70), progestins (9, 10), and androgens (9). The sequences
that confer this hormone inducibility on the MMTV pro-
moter have been extensively characterized and have been
collectively called the hormone response element (HRE).
This element, which has the properties of a steroid-depen-
dent transcriptional enhancer, consists of sequences within
the proviral long terminal repeat (LTR) approximately be-
tween positions -200 and -80 with respect to the start of
transcription (27, 34, 37, 57). Analysis of MMTV proviral
chromatin in isolated nuclei has revealed a hormone-induc-
ible site of DNase I hypersensitivity within the HRE; the
induction of this hypersensitive site parallels the transcrip-
tional activation of the MMTV promoter and presumably is
the direct result of a receptor interacting with the HRE (55,
72). Further studies have shown that the HRE contains
multiple binding sites for purified hormone receptor com-
plexes in vitro (21, 22, 54, 61, 62, 71). The MMTV LTR also
contains a negative regulatory element (NRE) localized to 91
base pairs (bp) of DNA between bp -454 and -364, whose
role appears to be to repress the inherent basal activity of the
MMTV promoter; the ratio of gene expression in the pres-
ence of hormone to gene expression in the absence of
hormone is thus increased when the element is present (44).
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A second negative element has also been identified within
HRE sequences (33), but this element has not been demon-
strated to affect transcription in vivo unless it is present in
multiple copies.
In addition to the receptor-binding sites, sequences that
bind the cellular transcription factor nuclear factor 1 (NF-1)
have been identified within the MMTV LTR between about
positions -80 and -60 (14, 15, 50). Several studies have
suggested that this cellular protein acts as a necessary
transcription factor for hormone-induced transcription from
the MMTV promoter (5, 14, 15, 43), including the isolation of
a naturally occurring point mutation in the NF-1-binding site
of a transcriptionally defective endogenous MMTV provirus
(32).
Beyond the receptor and NF-1-binding sites, little is
known of which, if any, other DNA sequence elements are
necessary for accurate and efficient transcription from the
MMTV promoter, although several studies have suggested
that additional factors are required. In one study employing
deletion and linker-scanning (LS) analysis, the binding site
for NF-1, as well as a sequence located around a TATA
element near position -30, was implicated in hormone-
mediated transcription (5); however, the extensive sequence
modifications introduced in these experiments did not allow
detailed delineation of specific sequence requirements. In
another study, exonuclease III protection experiments in
isolated nuclei were used to demonstrate binding of cellular
factors between positions -82 and +12; the exonuclease III
boundary at position -82 was shown to be the result of NF-1
binding, while the downstream boundary implicated at least
one other factor (15). Further work in vitro has demon-
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4478 TOOHEY ET AL.
strated a DNA-binding factor in nuclear extracts that binds
to MMTV DNA and results in exonuclease III protection of
sequences between positions -42 and -4 (14), a region that
includes the TATA box.
The resolution of the questions of which factors are
involved in transcription from the MMTV promoter and how
these factors interact with the promoter and with each other
to result in hormone-regulated transcription awaits a more
detailed functional characterization of the MMTV promoter
itself. To this end, we report here the construction and
analysis of a number of mutated MMTV promoters, includ-
ing a set of LS mutations across the entire promoter region.
These experiments define at least three regions of the MMTV
promoter, in addition to the hormone receptor-binding sites,
which appear to be necessary for normal levels of transcrip-
tion. One region includes the TATA element, a second
consists of two 10-bp direct repeats within which are embed-
ded three sequences related to the octamer element (17, 52),
and a third consists of sequences that are recognized by
NF-1. The mutation-sensitive region containing octamer-
related sequences is specifically recognized by a nuclear
protein. In addition, we show that promoter mutations
resulting in apparent increased in vitro affinity for NF-1 do
not decrease the extent of hormone receptor-mediated tran-
scriptional activation, suggesting that the interaction of NF-1
with the promoter is not a primary target for such activation
and consistent with the idea that NF-1 binding is not rate
determining in transcription from the MMTV promoter.
MATERIALS AND METHODS
Plasmid constructions. All restriction and modification
enzymes were used according to the recommendations of the
supplier (New England BioLabs or Bethesda Research Lab-
oratories).
BAL 31 exonuclease was used to introduce 5' and 3'
deletions into the MMTV promoter. Ends of the deleted
fragments were made blunt by filling in with the Klenow
fragment of DNA polymerase I, synthetic BglII linkers
(AAGATCTT) were added at the deletion endpoints, and the
deleted promoters were recloned. Individual members of the
deletion sets were then sequenced on supercoiled plasmid
DNA to determine the precise deletion endpoints. Approx-
imately 300 deletion mutants were sequenced in order to
obtain the desired deletion sets. The LS mutations were
assembled by replacing a fragment of the appropriate 5'
deletion with the corresponding fragment of the appropriate
3' deletion. The resulting LS mutants were then sequenced
to verify their identity. The LS mutants, which contain the
wild-type sequence configuration of the MMTV promoter
between positions -363 (RsaI) and +133 (PvuII), are named
such that the numbers in parentheses indicate the endpoints
of the bases in the wild-type promoter that are replaced by
the synthetic linker. The LS plasmids also contain the
chloramphenicol acetyltransferase (CAT) reporter gene and
simian virus 40 sequences containing the small-t intron and
early poly(A) addition signal (Fig. 1). The LS plasmids do
not contain pBR322 sequences that have been shown to
exert an adverse effect on transient expression (56).
LS(-59/-38) was assembled by recombining the 5' por-
tion of LS(-59/-52) with the 3' portion of LS(-45/-38) to
construct a deleted promoter in which 22 bp of MMTV
sequences were removed and replaced by the 8-bp BglII
linker; this deleted promoter was designated LS(-59/
-38A14). To restore the wild-type spacing of other MMTV
promoter elements, a synthetic linker was inserted into the
MMTV200 bp \ \M 1
Proviral DNA
M13 pLSwtn
SV40
pBR322
FIG. 1. Structure of MMTV LTR and pLSwt. Plasmid pLSwt
(5.5 kilobases) contains MMTV LTR sequences from position -363
(RsaI) to +133 (PvuII) with respect to the transcription initiation
site. The positions of the HRE (M), NRE (EI), coding se-
quences for CAT (_), and simian virus 40 sequences that specify
poly(A) addition (LII) are indicated. Vector sequences are identical
to those in pLC1 and pGTC1, plasmids which we have described in
detail (44, 69).
unique BglII site to generate LS(-59/-38), in which 20 out
of 22 bp in this region of the promoter are altered (see Fig. 4).
Supercoiled monomer DNA was purified by alkaline ex-
traction (3) and CsCl-ethidium bromide equilibrium density
centrifugation followed by exhaustive dialysis against a
buffer containing 250 mM NaCl, 10 mM Tris hydrochloride
(pH 7.6), and 1 mM EDTA and ethanol precipitation. Inclu-
sion of the dialysis step after the centrifugation resulted in a
significant increase in gene expression from the transfected
DNA and increased reproducibility between different prep-
arations of the same plasmid. Plasmid concentrations were
determined by A260 and verified by visualization after agar-
ose gel electrophoresis and ethidium bromide staining. All
large-scale plasmid preparations were analyzed by sequenc-
ing of the promoter region before transfection.
Plasmids were propagated in Escherichia coli HB101.
Plasmid DNAs were sequenced by the chain termination
method (59) with supercoiled templates (12) and [oX-35S]
dATP (Dupont, NEN Research Products).
Site-directed mutagenesis. Site-directed mutagenesis was
performed as described by Kunkel et al. (31) by using
pGTL1, a plasmid identical to pLSwt (Fig. 1) except for
changes in several restriction sites outside the MMTV-CAT
transcription unit. Single-stranded pGTL1 DNA was iso-
lated from a dut ung E. coli host, taking advantage of the
M13 replication origin on the plasmid, and second-strand
synthesis was primed with synthetic 32-base oligonucleo-
tides (see Fig. 7A) synthesized on an Applied Biosystems
DNA synthesizer (Oligonucleotide Synthesis Service, De-
partment of Biochemistry and Biophysics, Texas A&M
University). Altered DNA sequences of the mutant promot-
ers were verified by dideoxy-DNA sequencing on plasmid
DNA as described above. Mutated MMTV promoter se-
quences were subcloned subsequent to site-directed muta-
genesis and DNA sequencing to ensure that the desired
mutations were the only sequence alterations in the plas-
mids.
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FUNCTIONAL ELEMENTS OF THE MMTV PROMOTER 4479
-100 -50 +1
wild type gagctctgagtgttctattttcctatgttcttttggaatttatccaaatcttatgtaaatgcttatgtaaaccaagatataaaagagtgctgattttttgagtaaacttg
-102/-95 gagctctAagATCtTtattttcctatgttcttttggaatttatccaaatcttatgtaaatgcttatgtaaaccaagatataaaagagtgctgattttttgagtaaacttg
-93/-85 gagctctgagtgttct-AAGATctTtgttcttttggaatttatccaaatcttatgtaaatgcttatgtaaaccaagatataaaagagtgctgattttttgagtaaacttg
-86/-79 gagctctgagtgttctattttccAaGhtCTttttggaatttatccaaatcttatgtaaatgcttatgtaaaccaagatataaaagagtgctgattttttgagtaaacttg
-74/-67 gagctctgagtgttctattttcctatgttcttttgAaG^tCTtccaaatcttatgtaaatgcttatgtaaaccaagatataaaagagtgctgattttttgagtaaacttg
-65/-58 gagctctgagtgttctattttcctatgttcttttggaatttatcAaGatcttatgtaaatgcttatgtaaaccaagatataaaagagtgctgattttttgagtaaacttg
-64/-57 gagctctgagtgttctattttcctatgttcttttggaatttatccaaGATCtTtgtaaatgcttatgtaaaccaagatataaaagagtgctgattttttgagtaaacttg
-59/-52 gagctctgagtgttctattttcctatgttcttttggaatttatccaaatcA TCTTatgcttatgtaaaccaagatataaaagagtgctgattttttgagtaaacttg
-58/-51 gagctctgagtgttctattttcctatgttcttttggaatttatccaaatctAaGltCTTtgcttatgtaaaccaagatataaaagagtgctgattttttgagtaaacttg
-52/-45 gagctctgagtgttctattttcctatgttcttttggaatttatccaaatcttatgtaaaGhTCtTtgtaaaccaagatataaaagagtgctgattttttgagtaaacttg
-46/-39 gagctctgagtgttctattttcctatgttcttttggaatttatccaaatcttatgtaaatgctAaGhtCTTccaagatataaaagagtgctgattttttgagtaaacttg
-45/-38 gagctctgagtgttctattttcctatgttcttttggaatttatccaaatcttatgtaaatgcttaAgATTTcaagatataaaagagtgctgattttttgagtaaacttg
-37/-30 gagctctgagtgttctattttcctatgttcttttggaatttatccaaatcttatgtaaatgcttatgtaaacAaGlTCTtaaaagagtgctgattttttgagtaaacttg
-36/-29 gagctctgagtgttctattttcctatgttcttttggaatttatccaaatcttatgtaaatgcttatgtaaaccaagatCtTaaagagtgctgattttttgagtaaacttg
-31/-24 gagctctgagtgttctattttcctatgttcttttggaatttatccaaatcttatgtaaatgcttatgtaaaccaagataAGaTCTTgtgctgattttttgagtaaacttg
-22/-15 gagctctgagtgttctattttcctatgttcttttggaatttatccaaatcttatgtaaatgcttatgtaaaccaagatataaaagagAAGTCttttttgagtaaacttg
-19/-12gagctctgagtgttctattttcctatgttcttttggaatttatccaaat2ttatgtaaatgcttatgtaaaccaagatataaaagagtgcA2Atctttgagtaaacttg
-18/-11gagctctgagtgttctattttcctatgttcttttggaatttatccaaatcttatitaaatgcttatltaaaccaagatataaaagagtgctAaGhtCttgagtaaacttg
-7/+1 gagctctgagtgttctattttcctatgttcttttggaatttatccaaatcttatgtaaatgcttatgtaaaccaagatataaaagagtgctgattttttgagAaGaTCtT
___-»»- »»-------- >>>>>>>>>> >>>>>» >>>>
HRC HRC NF-1 -------- -------- TATA
"octamers"
FIG. 2. Structure of LS mutations of the MMTV promoter. Wild-type sequences are in lowercase letters, while mutations introduced by
the BglII linker are in boldface capital letters. The name of each mutant refers to the positions of sequences replaced by the linker. The
locations of the TATA box, the 10-bp direct repeats containing sequences related to the octamer consensus, and recognition sequences for
NF-1 and the glucocorticoid hormone-receptor complex (HRC) are indicated.
Gel electrophoresis mobility shift assay. Nuclear extracts of
Ltk- cells were made according to the method of Dignam et
al. (16) with previously described modifications (32). Protein
concentration of the extract was determined by the method
of Bradford (4) with bovine serum albumin as a standard. Gel
electrophoresis mobility shift assays for NF-1 were per-
formed by a method based on the procedure of Schneider et
al. (64) with a probe consisting of complementary 32-base
oligonucleotides (see Fig. 7A) containing the MMTV NF-1
site (extending from position -84 to position -53) as previ-
ously described (32).
Protein binding to the MMTV octamer-related sequences
was assessed with a 41-bp probe containing MMTV se-
quences from position -67 to -33 flanked by BamHI and
BglII restriction sites and labeled with polynucleotide kinase
and [_y-32P]ATP (3,000 Ci/mmol; Dupont, NEN). The binding
reaction mixtures contained 9 fmol of labeled oligonucleo-
tide, 9 jig of nuclear extract protein, 1 ,ug of poly(dI-dC), and
various amounts of competitor DNA in a buffer composed of
50 mM Tris hydrochloride (pH 7.9), 1 mM EDTA, 1 mM
dithiothreitol, 12.5 mM MgCl2, 100 mM KCI, and 20%
glycerol. These mixtures were incubated for 15 min on ice
and then loaded on a 4% polyacrylamide gel (acrylamide-
bisacrylamide [29:1]) containing 0.1 M Tris borate (pH 8.3),
2 mM EDTA, and 10% glycerol and electrophoresed at 4°C
at 20 V/cm in the same buffer without glycerol. The gel was
dried and exposed for 18 h to XAR-5 film (Eastman Kodak
Co.) with an intensifying screen.
Competitor DNAs derived by polymerase chain reaction
were prepared by amplification of 25 ng of plasmid DNA.
The primers were 5'-CTGAGTGTTC TAGATTCCTA TG
TTCT-3' and 5'-GTGAATGTTA GGATCCTTGC AAGT
TT-3'. These primers resulted in an amplified product con-
sisting of MMTV sequences from position -104 to +20; the
primers introduced base changes at positions -92, -91, +5,
+6, and +7 which constructed restriction sites in the ampli-
fied DNA. Amplification was performed in a final volume of
100 ,ul at a total primer concentration of 1 ,uM with 2.5 U of
Taq polymerase (Cetus Corp.) according to the recommen-
dations of the supplier. Forty amplification cycles were
performed at 91°C for 1 min, 45°C for 1 min, and 72°C for 1
min. Following amplification, samples were extracted with
chloroform, phenol-chloroform (1:1), and chloroform and
were then ethanol precipitated. DNA concentrations were
then determined by A260, and the integrity of the amplified
product was verified by gel electrophoresis.
Transfections and CAT assays. Mouse Ltk- cells (30) were
transfected by the DEAE-dextran procedure coupled with a
dimethyl sulfoxide shock (36) as previously described in
detail (69). Plasmid DNA was present at a concentration of
1.2 nM in the transfections unless otherwise indicated in the
figure legends. Five micrograms of extract protein was
assayed for 30 min for extracts from cells treated with
dexamethasone, while 35 to 40 ,ug of protein was assayed for
2 h for extracts from cells grown in the absence of hormone.
In both cases, the measured activity was within the linear
range of the assay.
Quantitative RNase mapping by RNase T2 protection was
performed as previously described for RNase T1 (69).
MMTV-CAT expression was measured relative to expres-
sion from the endogenous cellular ,-tubulin gene.
RESULTS
Construction of LS mutations in the MMTV promoter. In
order to elucidate the molecular mechanisms whereby
MMTV transcription is modulated by the HRE and NRE, it
is necessary to understand what determines the basal level of
transcription from the MMTV promoter. For our purposes,
we have defined the MMTV promoter as the DNA sequence
elements which are sufficient for basal levels of transcription
but which do not specify hormone responsiveness. By this
definition, the MMTV promoter has previously been shown
to extend no more than 109 bp 5' of the transcription start to
an SstI site within the LTR (Fig. 1) (34, 44). This 109-bp
region contains a number of sequences of potential impor-
tance in MMTV transcription (Fig. 2). Two binding sites for
the glucocorticoid hormone-receptor complex are present
(54, 61, 62); both of these sites contain a copy of the
consensus hexamer present in most DNA sequences recog-
nized by the receptor (TGTTCT) (for a review, see reference
2) as well as the binding site for NF-1 (14, 15, 50). This region
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CAT Activity (nmol.min-'.mg-1)
+dex
5.38 ± 0.85 (6)
1.02 ± 0.23 (3)
2.91 ± 0.23 (3)
2.77 ± 0.41 (3)
1.90 ± 0.12 (3)
1.67 ± 0.08 (3)
7.77 ± 0.83 (5)
4.07 ± 0.78 (5)
3.81 ± 0.55 (5)
2.60 ± 0.16 (3)
2.47 ± 0.24 (3)
2.54 ± 0.67 (3)
0.96 ± 0.28 (3)
0.98 ± 0.29 (3)
0.42 ± 0.03 (3)
3.21 ± 0.13 (3)
4.80 ± 0.60 (3)
4.76 ± 0.93 (4)
3.44 ± 0.52 (3)
-dex 0
0.130 ± 0.017 (6)
0.050 ± 0.009 (3)
0.057 ± 0.005 (3)
0.147 ± 0.018 (3)
0.038 ± 0.008 (3)
0.024 ± 0.003 (3)
0.071 ± 0.010 (3)
0.061 ± 0.013 (3)
0.050 ± 0.008 (3)
0.030 ± 0.006 (3)
0.023 ± 0.001 (3)
0.076 ± 0.008 (5)
0.017 ± 0.004 (3)
0.015 ± 0.005 (3)
0.005 ± 0.001 (3)
0.054 ± 0.012 (3)
0.145 ± 0.025 (3)
0.119 ± 0.021 (3)
0.108 ± 0.019 (3)
Relative CAT Activity
IEI
- i i~~~~~~~~~~~
-I I
FIG. 3. CAT activity directed by promoters containing LS mutations. Plasmids containing LS mutations were transfected into Ltk- cells
at a DNA concentration of 1.2 nM. Numerical values represent the means of absolute CAT specific activities of extracts of transfected cells
± the standard errors of the means with the number of independent transfections performed shown in parentheses. To compare the relative
effects of the LS mutations on transcription in the presence (_) and the absence (Lii) of dexamethasone (dex), the data are shown
graphically as CAT expression which has been normalized to that obtained from LSwt under the same transfection conditions.
of the LTR also contains a TATA element. Between the
NF-1 site and TATA box are two direct repeats of the 10-bp
sequence CTTATGTAAA; within the region containing
these repeats are three sequences related to the promoter
element known as the octamer (ATGCAAAT) (17, 52).
In order to investigate the functional significance of se-
quences in the MMTV promoter, LS mutations (40) across
the MMTV LTR from position -102 to + 1 relative to the site
of transcription initiation were constructed. The mutations
were introduced within the context of LTR sequences be-
tween positions -363 (RsaI) and +133 (PvuII) (Fig. 1). This
region includes all of the sequences composing the HRE (27,
34, 37, 57) but not those of the NRE (44); this sequence
context therefore allows determination of both basal and
hormone-induced transcriptional activity without promoter
repression due to the NRE. Downstream of the MMTV
promoter in each construct was the bacterial CAT gene
followed by the simian virus 40 small-t intron and sequences
necessary for poly(A) addition similar to other plasmids we
have described (44, 69) (Fig. 1).
The oligonucleotide linker chosen for mutagenesis was 5'-
d(AAGATCTT)-3'. This linker, which contains a BglII
restriction site, possesses the same G+C content as the
MMTV promoter region (25%) and should, therefore, mini-
mize any nonspecific sequence effects of the linker insertions
on transcription. The LS mutations are named such that the
numbers correspond to the nucleotides replaced by the
linker. With one exception, LS(-93/-85), each of the mu-
tant promoters analyzed contained an exact replacement of
the wild-type promoter sequences by those of the synthetic
linker and maintained, therefore, the relative positioning of
the unaltered MMTV sequences (Fig. 2). Some LS muta-
tions introduced only slight alterations in MMTV sequences
[for example, only 2 bp were altered in LS(-65/-58)], while
in others up to 8 bp were altered [LS(-59/-52)].
Transcriptional activity of mutant promoters. Plasmids
containing each of the LS mutants were transfected into
mouse Ltk- cells by the DEAE-dextran dimethyl sulfoxide
shock procedure (36) as previously described in detail (69).
In some experiments, the synthetic glucocorticoid dexameth-
asone was added 40 h after transfection to a concentration of
10-7 M, and 18 h later, cells were harvested and crude
extracts were assayed for CAT activity (69) and total protein
(4). We have previously demonstrated, with a wide variety
of MMTV plasmid constructions similar to those containing
the LS mutations, that CAT activity is linearly related to the
abundance of RNA transcripts correctly initiated within the
MMTV LTR (44, 69); this observation was confirmed in the
present study (see below). CAT expression from MMTV
promoters containing the LS mutations is shown in Fig. 3, in
which the absolute levels of CAT expression are shown
numerically and the expression relative to the wild-type
promoter is shown graphically. For ease in comparing the
effects of the LS mutations in the presence and absence of
glucocorticoids, the values in the bar graph have been
separately normalized to the corresponding wild-type levels
for transfections performed in the presence or absence of
dexamethasone. A number of LS mutations affected basal or
hormone-induced transcription or both, and these results are
discussed in detail below (see Discussion).
In order to verify that the altered levels ofCAT expression
obtained with the promoters containing the LS mutations
were reflecting alterations in MMTV transcription, an
RNase T2 protection experiment was performed. Selected
LS mutants were transfected into mouse Ltk- cells, and
MMTV-CAT transcripts were quantitated relative to an
internal standard of mRNA from the endogenous mouse
1-tubulin gene (44, 69). Transcription from mutant MMTV
promoters determined by this method was in good agree-
ment with that assessed by CAT assay (data not shown), a
Plasmid
LSWt
LS(-102/-95)
LS(-93/-85)
LS(-86/-79)
LS(-74/-67)
LS(-65/-58)
LS(-64/-57)
LS(-59/-52)
LS(-58/-51)
LS(-52/-45)
LS(-46/-39)
LS(-45/-38)
LS(-37/-30)
LS(-36/-29)
LS(-31/-24)
LS(-22/-1 5)
LS(-1 9/-12)
LS(-1 8/-l1)
LS(-7/+1)
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A
B
.10-
.5
c.)
a)
.2)
.08
.06
.04'
.02
-50
cAAGATCTTatgcttatgtaaacc
cttatgtaaaGATCtTtgtaaacc
cttatgtaaatgcttaAgATCTTc
co*...AAGATCTT .-o--c
cAAGATCCaGGATCCTGgATCTTc
cttatgtaaatgcttatgtaaacc
- b - .
0 0.5 1.0
DNA (nM)
:>
0)
.>t
aL)
:r
1.5
1 + dex
1.0
.8-
.60
.4-
.2
0
LS(-59/-52)
LS(-52/-45)
LS(-45/-38)
LS(-59/-38 Al 4)
LS(-59/-38)
wild type
0.5 1.0
DNA (nM)
FIG. 4. Transcription from MMTV promoters with mutations in
all three octamer-related sequences. (A) Sequences of promoter
mutations. MMTV sequences from position -60 to -37 are shown,
with the wild-type sequence at the bottom. The three octamer-
related sequences and two 10-bp repeats are indicated. LS(-59/
-38) was constructed by insertion of an oligonucleotide into
LS(-59/-38A14) and contains sequences similar to the combination
of mutations present in LS(-59/-52), LS(-52/-45), and LS(-45/
-38). (B) CAT activity directed by LS(-59/-38). LSwt (0) or
LS(-59/-38) (0) DNA was transfected into Ltk- cells. Relative
CAT activity (with expression from LSwt at 1.2 nM in the presence
of hormone defined as 1.0) is shown as a function of DNA concen-
tration in the transfections. Cells were propagated either in the
absence (left) or presence (right) of 10-7 M dexamethasone (dex).
result we have repeatedly verified in transfection experi-
ments with a number of related plasmids (44, 69).
Promoter mutations in all three octamer-related sequences.
Of particular interest are the LS mutations in the 10-bp
repeats containing octamer-related sequences [LS(-59/
-52), LS(-58/-51), LS(-52/-45), LS(-46/-39), and LS
(-45/-38)]. Basal promoter activity from LS(-52/-45) and
LS(-46/-39), which alter the proximal 10-bp repeat and the
two most proximal octamer-related elements, was impaired
to an extent roughly equivalent to that of promoters with
mutations in the NF-1-binding site, indicating the impor-
tance of this region of the promoter in MMTV transcription.
However, glucocorticoid-induced transcription from these
promoters was decreased by a factor of only about two. The
potential role of sequences in the distal 10-bp repeat or the
most distal octamerlike element is not clearly revealed by
the LS mutations; LS(-59/-52) and LS(-58/-51) caused a
reduction by a factor of two to three in basal promoter
activity, but their effect on hormone-induced transcription
was a reduction by a factor of only about 1.3. It is possible
that these more distal sequences are not critical for MMTV
promoter activity. However, it is also possible that relatively
small effects of mutations in this region of the promoter are
the result of the repeated nature of the sequences, which
may be, at least to some extent, functionally redundant. To
directly test this idea, a mutated promoter [LS(-59/-38)] in
which this region was more extensively altered was con-
structed (Fig. 4). This promoter was created by insertion of
an oligonucleotide into the deleted promoter present in
LS(-59/-38A14) (see Materials and Methods). The ends of
the mutated segment of LS(-59/-38) have a DNA sequence
identical to those in LS(-59/-52) and LS(-45/-38), muta-
tions which, when present alone, decreased hormone-in-
duced transcription by a factor of two or less. The mutated
promoter in LS(-59/-38) is very similar to the promoter
that would result from the combination of the base substitu-
tions in LS(-59/-52), LS(-52/-45), and LS(-45/-38).
Transcriptional activity from LS(-59/-38) was decreased
by a factor of at least 10 relative to the wild-type promoter
over a range of DNA concentrations in both the presence
and absence of glucocorticoids, confirming the importance
of this entire region of the promoter for both basal and
hormone-induced transcription (Fig. 4).
The DNase I footprint for NF-1 on the MMTV promoter
extends from position -80 to -58 (50), and NF-1 binding to
the promoter leads to an exonuclease III boundary at posi-
tion -56 (14). The MMTV sequences modified in LS(-59/
-38) therefore included a few nucleotides of these protected
regions. Although a number of studies have indicated that
the sequences modified in LS(-59/-38) are too far removed
from the core recognition sequence to affect NF-1 recogni-
tion (see Discussion), we employed a gel electrophoresis
mobility shift assay (19, 20) to address directly whether NF-1
binding to the promoter had been altered in LS(-59/-38). A
synthetic 32-bp oligonucleotide containing MMTV se-
quences from position -84 to -53 was 5'-end labeled and
used as a probe. Nuclear extracts from Ltk- cells served as
a source of NF-1, and a band of retarded mobility was
observed, indicative of a protein-DNA complex (Fig. 5A,
lane 1). Competition experiments have verified that the
retarded band is due to specific recognition of the NF-1 site
(reference 32 and data not shown). To assess NF-1 binding
to mutated promoter sequences, we prepared competitor
DNAs composed of MMTV sequences from position -104
to +20 by the polymerase chain reaction technique (45).
Efficient competition was observed when the competitor was
derived from the wild-type MMTV promoter (Fig. 5A, lanes
2 to 4), while a competitor prepared from LS(-74/-67),
which alters the NF-1 core recognition sequence and has a
relatively severe effect on MMTV promoter activity, showed
little or no competition (Fig. 5A, lanes 5 to 7). A competitor
DNA derived from LS(-59/-38) was as effective a compet-
itor as that derived from the wild-type promoter (Fig. 5B,
lanes 5 to 7). It therefore appears that impaired promoter
recognition by NF-1 is not the source of the altered tran-
scriptional activity of LS(-59/-38). This point is addressed
further in Discussion.
A nuclear protein recognizes octamer-related sequences in
the MMTV promoter. To determine whether a nuclear pro-
tein recognizes the promoter region containing the 10-bp
repeats and the octamer-related sequences, we took advan-
tage of a gel electrophoresis mobility shift assay similar to
that described above. Nuclear extracts of Ltk- cells were
incubated with a synthetic oligonucleotide containing
MMTV sequences from position -67 to -33. Two bands of
retarded mobility indicative of protein-DNA complexes
were observed; both of these bands were subject to compe-
tition by sequences from this region of the MMTV promoter
but not by unrelated sequences (Fig. 6). One or more
proteins in the nuclear extract, therefore, specifically recog-
nize this region of the MMTV promoter.
Mutations that increase affinity of NF-1 for the MMTV
promoter. Exonuclease III protection experiments in iso-
lated nuclei have detected binding of NF-1 to the MMTV
promoter only when the nuclei are isolated from glucocorti-
coid-treated cells (15). This observation has suggested a
model in which one role of the activated glucocorticoid
- dex
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FIG. 5. NF-1 binding to mutated MMTV promoters assessed by
gel electrophoresis mobility shift assay. A 5'-end-labeled, double-
stranded oligonucleotide corresponding to the wild-type MMTV
sequence from position -84 to -53 (30 fmol) was incubated with 4
jig of nuclear extract protein from Ltk- cells in the presence of poly
(dI-dC) and various competitor DNAs corresponding to MMTV
sequences from position -104 to +20. The products are displayed as
autoradiograms after fractionation by polyacrylamide gel electro-
phoresis. The origins of the gels (0) and the positions of bands
corresponding to free DNA (F) and the retarded band indicative of
NF-1 binding (C) are indicated. (A) NF-1 binding to LS(-74/-67).
Lanes 1 and 8, No competitor; lanes 2 to 4, competitor derived from
LSwt in 10-, 50-, and 100-fold molar excess, respectively; lanes 5 to
7, competitor derived from LS(-74/-67) in 10-, 50-, and 100-fold
molar excess, respectively; lane 9, no nuclear extract. (B) NF-1
binding to LS(-59/-38). Lanes 1 and 8, No competitor; lanes 2 to 4,
competitor derived from LSwt; lanes 5 to 7, competitor derived
from LS(-59/-38); lane 9, no nuclear extract. Amounts of compet-
itor are identical to those in the corresponding lanes in panel A.
receptor protein is to facilitate or stabilize binding of NF-1 to
the promoter. A prediction of this model is that promoter
mutations that lead to increased inherent affinity for NF-1
should increase the basal promoter activity and render it less
responsive to hormonal activation. To explore this idea, we
constructed mutations in the MMTV NF-1 site by oligonu-
cleotide-directed, site-specific mutagenesis. Two mutant
promoters based on pGTL1, a plasmid identical to pLSwt
(Fig. 1) except for changes in several restriction sites outside
the MMTV-CAT transcription unit, were constructed. The
mutations created NF-1-binding sites which more closely
match the consensus NF-1 site (Fig. 7A) and which were
therefore expected to have higher affinity for NF-1. One of
the mutated NF-1 sites contains a transversion (T to G) at
position -67 to introduce a consensus sequence into the
proximal half of the symmetrical NF-1 site (pGTL2), while
the second mutated promoter contains a complete consensus
NF-1 site obtained by introducing two additional transver-
sions (AA to CT at positions -73 and -72) (pGTL4). While
different studies have reported different NF-1 consensus
sequences (23, 28, 35, 64), the consensus shown in Fig. 7A
(derived from reference 28) maintains perfect symmetry in
the two halves of the site.
FIG. 6. Protein binding to MMTV octamer-related sequences
assessed by gel electrophoresis mobility shift assay. A 5'-end-
labeled, double-stranded oligonucleotide containing MMTV se-
quences from position -67 to -33 (9 fmol) was incubated with 9 jig
of nuclear extract protein from Ltk- cells in the presence of poly
(dI-dC). The products are displayed as an autoradiogram after
fractionation by polyacrylamide gel electrophoresis. The origin of
the gel (0) and the positions of bands corresponding to free DNA (F)
and retarded bands indicative of protein-DNA complexes (Cl and
C2) are shown. Unlabeled, double-stranded competitor oligonucle-
otides were used to assess the specificity of observed complexes for
the labeled sequence. Lane 1, No extract added; lane 2, no compet-
itor; lanes 3 and 4, NF-1(wt/wt) competitor (Fig. 7A) in 50- and
100-fold molar excess, respectively; lanes 5 and 6, a competitor
consisting of a 32-bp oligonucleotide containing no sequences re-
lated to the MMTV promoter in 50- and 100-fold molar excess,
respectively; lanes 7 and 8, a competitor consisting of an oligonu-
cleotide containing MMTV sequences from position -67 to -33 (the
same oligonucleotide used as a probe) in 50- and 100-fold molar
excess, respectively.
The binding affinity of mutated MMTV NF-1 sites relative
to the wild-type site was estimated with a gel electrophoresis
mobility shift assay with the synthetic 32-bp oligonucleotide
containing the wild-type MMTV NF-1 site as described
above. To assess the relative affinity of NF-1 binding to the
wild-type and mutant promoters, a competition experiment
(Fig. 7B) in which competitor DNAs consisted of unlabeled
32-bp oligonucleotides containing the wild-type and mutated
NF-1 sites was performed. This experiment revealed signif-
icant differences in the apparent affinity of NF-1 for the three
binding sites in the order predicted on the basis of the
relationship with the consensus NF-1 site: the wild-type
NF-1 site [NF-l(wt/wt)] was significantly lower in affinity
than the site containing the consensus sequence in the
proximal symmetry element [NF-1(wt/c)], which was signif-
icantly lower in affinity than the complete consensus NF-1
site [NF-l(c/c)]. Determining the exact quantitative differ-
ences in binding affinity among the three sites is difficult
because of the crude nature of the protein fraction. How-
ever, on the basis of densitometric scanning of the autora-
diogram shown in Fig. 7B, the NF-l(wt/c) and NF-l(c/c)
sites were estimated to have binding affinities 10 and 50 times
higher than that of the wild-type site, respectively. These
estimates are consistent with the results of Meisterernst et
al. (42), who quantitated affinities of purified porcine liver
NF-1 with a number of mutated NF-1 sites. Their results
showed that mutations in an NF-1 site of the type TTGGCN5
GCCAA (similar to what we have defined as the consensus
site) to TTGGAN5GCCAA (with a distal half-site similar to
that found in MMTV) reduces affinity for NF-1 by a factor of
5 to 10. Similarly, a mutation of G to T in the first base of the
GCCAA element (similar to the proximal half-site found in
MMTV) reduces affinity by a factor of five. We therefore
believe that our estimates based on crude extracts are
realistic.
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FIG. 7. Sequences of mutated promoters containing altered NF-
1-binding sites. MMTV sequences between positions -84 and -53
with respect to the transcription initiation site are shown. The
consensus NF-1-binding site derived from the analysis of multiple
high-affinity sites (28) is shown at the top with the region of dyad
symmetry indicated by arrows. These sequences correspond to the
primers used in site-directed mutagenesis. (B) NF-1 binding to
mutated MMTV promoters assessed by gel electrophoresis mobility
shift assay. A 5'-end-labeled, double-stranded oligonucleotide cor-
responding to the wild-type [NF-1(wt/wt)] 32-bp sequence shown in
panel A (20 fmol) was incubated with 7 ,ug of nuclear extract protein
from Ltk- cells in the presence of poly(dI-dC). The products are
displayed as an autoradiogram after fractionation by polyacrylamide
gel electrophoresis. The origin of the gel (0) and the positions of
bands corresponding to free DNA (F) and the retarded band
indicative of NF-1 binding (C) are indicated. Unlabeled, double-
stranded competitor DNAs corresponding to the sequences shown
in panel A were used to assess the relative affinity of NF-1 for
wild-type and mutant MMTV promoters. Lane 1, No competitor
DNA; lanes 2 and 3, NF-1(wt/wt) competitor in 8- and 38-fold molar
excess, respectively; lanes 4 and 5, NF-1(wt/c) competitor in 8- and
38-fold molar excess, respectively; lanes 6 and 7, NF-1(c/c) com-
petitor in 8- and 38-fold molar excess, respectively; lane 8, no
extract added.
Transcriptional activity of promoters with increased NF-1
affinity. A comparison of the transcriptional activities of
promoters containing wild-type (pGTL1) and complete con-
sensus (pGTL4) NF-1-binding sites is shown in Fig. 8. At
low concentrations of DNA, transcriptional activity of the
promoter with the consensus binding site was increased
about twofold in both the presence and the absence of
hormone; however, at 1.2 nM DNA (the concentration used
in the experiments shown in Fig. 3), the difference between
the two promoters was only about 20%. The increased
apparent affinity for NF-1 did not affect the extent of
receptor activation of promoter activity; the hormone induc-
tion ratio of wild-type and mutant promoters was essentially
constant (15- to 20-fold hormone induction in these experi-
ments) and did not vary with DNA concentration. Transfec-
tion experiments with the promoter containing a consensus
sequence only in the proximal NF-1 half-site (pGTL2) gave
CAT expression intermediate to that given by the two
constructions containing the wild-type or complete consen-
sus NF-1 sites (data not shown).
DISCUSSION
Mutations in steroid hormone-receptor binding sites. LS
mutations LS(-102/-95), LS(-93/-85), and LS(-86/-79)
.52:
0)
.16
0
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DNA (nM)
FIG. 8. Transcriptional activity of MMTV promoters with al-
tered NF-1 sites. Ltk- cells were transfected with pGTL1 (squares)
or pGTL4 (circles) at various DNA concentrations. Filled symbols
indicate CAT expression in the presence of lo-7 M dexamethasone,
while open symbols indicate expression in the absence of this
hormone. The CAT activities shown are the averages of three to five
independent transfections and are expressed as relative activities.
The insert shows CAT expression in the absence of hormone with an
expanded scale.
overlap two DNase I footprints of glucocorticoid hormone-
receptor complexes (54, 62), each of which contains a
hexameric TGTTCT consensus binding site. LS(-102/-95)
disrupts the more distal of these hexamer consensus binding
sequences (located between positions -99 and -94) in four
of the six hexamer consensus bases, including the two G
residues that have been previously shown to be protected
from methylation in the presence of the hormone receptor in
vitro (61). The glucocorticoid-induced transcriptional activ-
ity of this mutant was reduced by a factor of five. In a similar
manner, the mutations introduced by LS(-86/-79) alter four
nucleotides within the more proximal consensus hexamer for
glucocorticoid receptor binding between positions -84 and
-79, but this mutation resulted in a decrease in glucocorti-
coid-induced CAT expression by a factor of only about two.
It is unclear whether the difference in sensitivity of these two
regions, both of which bind the receptor in vitro, reflects
specific differences in the mutations with respect to the
consensus binding site sequence or the inherent differences
in the necessity of the two sites for hormone regulation of
MMTV transcription. Our results are generally consistent
with the work of Cato et al. (11), who found that overall
steroid responsiveness was dependent on the two proximal
receptor-binding sites mutated in our study in addition to
more distal receptor-binding sites also present in the HRE.
This finding is in contrast to an earlier report in which the
proximal sites were found to be relatively unimportant (5).
The mutations introduced by LS(-93/-85), which alters
the sequence between the two glucocorticoid receptor-bind-
ing consensus sequences, resulted in a 50% decrease in
hormone-induced CAT activity, suggesting, as has been
previously reported (5), that the sequences outside of the
hexamer consensus sites can affect the levels of hormone-
mediated transcription. However, since LS(-93/-85) con-
tains a 1-bp deletion relative to the normal MMTV sequence
organization, it is also possible that this positional alteration
is responsible for the decreased activity.
In the absence of hormone, transcription from the MMTV
promoter became, not surprisingly, less dependent on the
receptor-binding sites. This was particularly apparent with
LS(-86/-79), in which transcriptional activity was not at all
affected in the absence of hormone. It is not clear, however,
why LS(-102/-95) and LS(-93/-85) should result in a
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decrease of a factor of two in CAT expression in the absence
of glucocorticoids. One possibility is that the media in which
the transfected cells were propagated contained nontrivial
amounts of glucocorticoid hormones and that the levels of
gene expression we have defined as hormone independent in
reality reflect some amount of hormone induction. We
believe this is unlikely, however, since transcription from
LS(-86/-79) was affected only in the presence of hormone
(Fig. 3). Alternatively, it is possible that an additional basal
promoter element overlaps the receptor-binding site that is
altered in LS(-102/-95), and we are currently investigating
this possibility.
One mutation-sensitive region of the MMTV promoter
contains a TATA element. Our LS mutations have defined at
least three mutation-sensitive regions of the MMTV pro-
moter. One such region is defined by LS(-37/-30), LS(-36/
-29), and LS(-31/-24) and contains a TATA element.
LS(-37/-30) alters six bases in this region, at least two of
which are in the TATA element, while LS(-36/-29) alters
only two bases (-31 and -29), both of which are in the
TATA sequence. The activity of both of these mutant
promoters is decreased by a factor of six to eight relative to
the wild type. LS(-36/-29) changes only two bases with
respect to the wild-type sequence (ATCTTAA versus ATAT
AAA), suggesting that at least one of these bases may be
intimately involved with the binding of the mouse homolog
of transcription factor TFIID (48). LS(-31/-24), which also
alters sequences within the TATA element, directed the
lowest transcriptional activity of any of the LS mutants. The
lower activity of this mutant, compared with those of the
other TATA mutants, is possibly due to the more complete
disruption of the TATA-like sequences in this promoter (Fig.
2).
While the importance of the TATA element in MMTV
transcription cannot be considered surprising, previous mu-
tational analysis had not convincingly established its role.
The LS mutations of Buetti and Kuhnel (5) in this region of
the promoter contained a deletion between positions -37
and -11, altering spacing between other promoter elements
and the transcription start site. In addition, the transcrip-
tional activity of this mutated promoter was not determined
in the absence of glucocorticoid induction, and therefore no
conclusion regarding the significance of the mutated se-
quences on basal transcription could be made.
The transcriptional activity of mutations 3' of the TATA
element increased to essentially wild-type levels, indicating
that sequences altered in LS(-22/-15), LS(-19/-12), LS
(-18/-11), and LS(-7/+l) are not important for basal or
hormone-induced transcription.
A second mutation-sensitive region contains two 10-bp
direct repeats and three octamer-related sequences. MMTV
sequences between positions -60 and -38 contain two
direct repeats of the 10-bp sequence CTTATGTAAA, and
embedded within these direct repeats are three homologies
to the promoter element known as the octamer (ATG
CAAAT) (17, 52). The octamer element is present in, among
others, the promoters of the immunoglobulin heavy- and
light-chain genes (17, 24, 39, 52), the herpes simplex virus
thymidine kinase gene (53), small nuclear RNA genes (1, 8,
38, 46), the histone H2B gene (18), and simian virus 40 (67),
in each of which it has been shown to be required for optimal
levels of transcription. The octamer sequence has been
shown to be the binding site for at least two proteins: one,
termed Oct-1 (68), OTF-1 (18), OBP100 (67), or NF-A1 (66),
which apparently is present in all cell types, and another,
termed Oct-2 (13), OTF-2 (63), or NF-A2 (66), which appears
to be lymphoid specific (65, 66). Oct-1 has been shown to be
identical to nuclear factor III, a protein originally identified
as being required for adenovirus DNA replication (51). The
genes encoding Oct-1 and Oct-2, oct-i and oct-2, have been
cloned (13, 68); the deduced amino acid sequences of the
encoded proteins contain a conserved domain termed the
POU domain, which is also present in pit-i, the product of
which encodes a pituitary-specific transcription factor, and
unc-86, a gene involved in cell differentiation in Caenorhab-
ditis elegans (26). Four additional genes encoding POU
domains have recently been cloned (25). In the MMTV
promoter, the distal octamer-related sequence is located
between positions -57 and -50 (ATGTAAAT, a seven-of-
eight match to the consensus), the central octamer-related
sequence is between positions -51 and -44 (ATGCTTAT, a
six-of-eight match), and the proximal octamer-related se-
quence is between -45 and -38 (ATGTAAAC, a six-of-
eight match).
The most severe effect of mutations in this region of the
promoter was observed on basal transcription, where LS
(-52/-45) and LS(-46/-39) decreased CAT expression by
a factor of four to six, a decrease comparable to that in the
mutations in the NF-1-binding site. These two LS mutations
alter the proximal 10-bp element and the central and proxi-
mal octamer-related sequences. Mutations in the distal 10-bp
element or the distal octamer-related sequence [LS(-59/
-52) and LS(-58/-51)] decreased basal transcription by a
factor of two to three. None of the LS mutations in this
region of the promoter reduced hormone-induced transcrip-
tion by a factor of more than two. These data indicated that
at least the proximal portion of the 10-bp elements or
octamer-related sequences plays a functional role in the
MMTV promoter but left unclear the role of the repeated
nature of these elements. The importance of this repeated
nature was defined by the dramatically decreased transcrip-
tional activity of LS(-59/-38) (Fig. 4), in which all of the
repeated segments in this region of the promoter are altered.
It is possible that the two 10-bp repeats or the three
octamer-related sequences are functionally redundant in a
manner similar to that previously observed with two G-C
boxes in the promoter of the herpes simplex virus thymidine
kinase gene (41). That is, mutations in the distal 10-bp repeat
or the distal octamer-related sequence have relatively little
effect on transcription in LS(-59/-52) or LS(-58/-51), but
similar sequence alterations within the context of additional
mutations in the proximal 10-bp repeat or the central and
proximal octamer-related sequences [LS(-59/-38)] de-
crease transcription significantly (Fig. 4).
Alternatively, it could be argued that the observed effect
of mutations in LS(-59/-38), which we ascribe to alter-
ations in the 10-bp repeat or octamer-related sequences, may
be an artifact of modifying sequences necessary for NF-1
binding on the 5' side and TFIID binding at the TATA
element on the 3' side. A number of considerations make this
possibility unlikely. First, if the observed effect of LS(-59/
-38) were simply to due a combination of sequence alter-
ations at the NF-1 site and TATA element, then the pre-
dicted magnitude of the effect would be expected to be the
product of the effects caused by LS(-59/-52) and LS(-45/
-38), since other sequences altered in LS(-59/-38) do not
overlap with the defined binding sites for NF-1 or the
putative TATA-binding factor (see below). However, the
observed transcription level from LS(-59/-38) was one-
fourth to one-third of the level predicted on the basis of this
premise in the presence of glucocorticoids and less than 1/10
of the predicted level in the absence of hormone, indicating
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that sequences altered in LS(-59/-38) but not altered in
LS(-59/-52) or LS(-45/-38) play a role in MMTV tran-
scription. Moreover, sequences altered in LS(-59/-38) do
not affect NF-1 binding, as determined by competition in a
gel electrophoresis mobility shift experiment (Fig. 5), nor do
they alter sequences required for NF-1 recognition, as
determined by Nilsson et al. (49) and Leegwater et al. (35).
Finally, with regard to the possible effect of LS(-59/-38) on
TFIID binding at the MMTV TATA element, several rele-
vant observations can be made. The first T of the TATA
element in the MMTV promoter is at position -32. LS(-59/
-38) thus introduces sequence alterations beginning 6 bp
upstream of TATA. DNase I footprints of the most highly
purified preparations of mammalian TFIID on the adenovi-
rus major late promoter have been shown to extend 6 and 9
bp upstream of TATA on the nontemplate and template
strands of DNA, respectively, while DNase I footprints on
the hsp7O promoter extend 4 and 6 bp upstream of TATA on
the nontemplate and template strands, respectively (48).
Footprinting with methidiumpropyl-EDTA iron(II), a chem-
ical reagent that is not subject to the steric constraints of an
enzymatic probe such as DNase I, has defined a TFIID
binding site on the adenovirus major late promoter extending
1 and 3 bp upstream of TATA on the nontemplate and
template strands, respectively (60). Purified TFIID from
Saccharomyces cerevisiae, which has been shown to func-
tion in vitro in a mammalian transcription system, generates
a DNase I footprint on the adenovirus major late promoter
that extends 4 and 6 bp upstream of TATA on the nontem-
plate and template strands, respectively (7). On the basis of
these experiments, it appears that mutations in LS(-59/-38)
are unlikely to affect sequences that are involved in TFIID
recognition. The binding studies described above did not
define the minimal sequence required for TFIID recognition,
however. At present, the best indication of the size of such
a minimal sequence comes from functional studies of pro-
moter activity. LS mutations of the herpes simplex virus
thymidine kinase promoter indicate that DNA 7 bp upstream
of the TATA sequence has no effect on promoter activity
(40), while a detailed set of point mutations in the ,-globin
promoter indicates that DNA within 2 bp of the TATA
element can be mutated without affecting promoter activity
(47); functional analysis thus limits the sequences important
for TFIID recognition to those very near the TATA se-
quence itself. These observations, coupled with the rela-
tively minor effect of LS(-45/-38) on MMTV promoter
activity (a reduction by a factor of two), lead us to conclude
that sequences this far removed from TATA are not likely to
have a significant effect on TFIID binding, and we believe
that the effect of LS(-59/-38) on MMTV transcription
cannot be ascribed to defects in recognition of the TATA
element.
The importance of the 10-bp repeat or octamer-related
sequences for MMTV transcription is further strengthened
by the identification of a protein that recognizes this region
of the promoter (Fig. 6). In addition, we have demonstrated
that an oligonucleotide containing MMTV octamer-related
sequences can specifically inhibit transcription from the
MMTV promoter in vitro, suggesting that the added oligo-
nucleotide titrates out a DNA-binding protein required for
transcription (J. Pierce and D. 0. Peterson, unpublished
observation). Several lines of evidence suggest that this
protein may be Oct-1, the ubiquitously expressed octamer-
binding protein. We have shown that an oligonucleotide
containing a consensus octamer can compete for binding
with MMTV sequences, and we have also demonstrated that
authentic Oct-1, expressed either in vitro or in E. coli from
the cloned cDNA (68), can specifically recognize this region
of the MMTV promoter. However, it is not completely clear
that Oct-1 is the factor involved in MMTV transcription. We
have not yet demonstrated an effect of authentic Oct-i on in
vitro transcription from the MMTV promoter, which would
confirm its functional role. In addition, we have purified a
protein that recognizes this region of the MMTV promoter
from mammalian nuclear extracts by DNA affinity chroma-
tography, and this protein is significantly smaller than Oct-1
(M. Huang and D. 0. Peterson, unpublished observation).
Finally, site-directed mutations in the MMTV promoter that
convert either the distal and proximal or all three octamer-
related sequences to consensus octamers result in a signifi-
cant decrease in promoter activity (J. W. Lee and D. 0.
Peterson, unpublished observation). More work will be
necessary to sort out these observations and definitively
characterize the factor that mediates the transcriptional
effect of the MMTV 10-bp repeats or octamer-related se-
quences.
A third mutation-sensitive region of the MMTV promoter
contains sequences bound by NF-1. A third region of the
MMTV promoter that is sensitive to the LS mutations is
defined by LS(-74/-67) and LS(-65/-58), both of which
direct transcription at approximately one-fifth to one-third of
the wild-type level in both the presence and the absence of
hormone. This region is resolved from mutations affecting
receptor-binding sites by LS(-86/-79), which has no effect
on basal transcription, and from promoter sequences more
proximal to the transcription start by LS(-64/-57). The
MMTV promoter in LS(-74/-67) contains base changes at
five positions, of which two (-74 and -68) are conserved
positions in the distal half of the NF-1 recognition site (28),
while LS(-65/-58) replaces bases only at positions -65 and
-63, with only the replacement at -65 altering a conserved
sequence in the proximal half of the NF-1 recognition site.
LS(-74/-67) was demonstrated to alter NF-1 recognition in
vitro (Fig. 5).
On the basis of some previous reports, a larger reduction
in promoter activity might have been expected from these
mutations; the insertion of as few as three bases between the
two NF-1 half-sites was reported to result in a decrease in
hormone-mediated transcription from the MMTV promoter
of greater than two orders of magnitude (43). Our results
correspond more closely to those obtained in the nucleotide
replacement mutagenesis experiments of Cato et al. (11), in
which complete alteration of the distal NF-1 half-site re-
sulted in a reduction by a factor of six to eight in glucocor-
ticoid-induced transcription. As in that study, both mutants
tested here maintained the wild-type spacing of sequences 5'
and 3' of the two NF-1 half-sites, and only a portion of the
sequences thought to be critical for recognition by NF-1 was
mutated. Therefore, one explanation for the difference be-
tween our results (as well as those of Cato et al. [11]) and
those of others is that promoters with one intact half-site
retain the ability, albeit impaired, to bind NF-1 (28). Such
weakened interactions may also be stabilized by the pres-
ence of additional proteins bound to this region of the
promoter. It is interesting to note that a boundary for
exonuclease III digestion in vitro has been observed with
purified NF-1 at position -68 (14), which is between the two
NF-1 half-sites, suggesting that both NF-1 half-sites need not
be occupied simultaneously in the MMTV promoter.
The decreased transcription from mutant promoters with
altered NF-1-binding sites indicates that this transcription
factor is required for basal as well as hormone-induced
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transcription (Fig. 3). Earlier studies have not been definitive
on the role of NF-1 in basal transcription from the MMTV
promoter. For example, oligonucleotide substitution muta-
genesis of the distal NF-I half-site results in reduction by a
factor of about two in basal transcription (11), but a naturally
occurring G-to-A transition at position -75 in endogenous
MMTV proviral DNA at genetic locus Mtv-17 significantly
decreases the affinity of NF-1 for the promoter and dramat-
ically affects glucocorticoid-induced transcription without an
apparent effect on promoter activity in the absence of
hormone (32). In addition, one study has included the
MMTV NF-1 site in the HRE sequences required to confer
maximum glucocorticoid inducibility to the herpes simplex
virus thymidine kinase promoter (57). However, the thymi-
dine kinase promoter employed in this study contained a
deletion of the endogenous NF-1 site present in distal
element 2 (28, 29, 40), and the effect of the MMTV NF-1 site
may have been to partially restore the deleted element. The
variable effects of mutations in the MMTV NF-1-binding site
on basal transcription can be interpreted in a consistent
manner if NF-1 binding, while being required for normal
levels of transcription from the wild-type MMTV promoter,
is not rate determining. Thus, if the step that is rate deter-
mining for basal transcription is sufficiently slow, significant
sequence alterations in the NF-1 site, such as those present
in the LS or insertion mutations, would be required in order
to decrease NF-1 affinity to an extent sufficient to make
NF-1 binding become the limiting factor in transcription. In
the presence of hormone, where the rate-determining step in
transcription is significantly faster, the decrease in NF-1
affinity caused by even the less extensive mutations (such as
the single point mutation in the endogenous provirus at
Mtv-17 [32]) may be sufficient to make NF-1 binding become
rate determining. The observation that mutant MMTV pro-
moters with increased apparent affinity for NF-1 do not
substantially increase basal transcription (Fig. 7 and 8) is
consistent with the idea that NF-1 binding is not rate-
determining.
The requirement for NF-1 in basal transcription from the
MMTV promoter is supported by a recent study of Buetti et
al. (6) and by our own in vitro transcription studies, in which
we have demonstrated a requirement for NF-1 (Pierce and
Peterson, unpublished observation).
It is interesting to note that an octamer-related sequence(ATCCAAAT, a seven-out-of-eight match to the consensus)
is present from position -68 to -61 within the NF-1-binding
site. This octamer-related sequence is apparently not recog-
nized by the same protein that binds MMTV DNA within the
10-bp repeats, since an oligonucleotide containing the NF-1
site (-84 to -53) does not compete for this protein (Fig. 6).
The MMTV promoter and hormone-induced transcription.
While a few of the LS mutants differentially affected tran-
scription depending on whether glucocorticoids were
present, the hormone induction ratio for all of the mutant
promoters varied by a factor of only about two up or down
relative to that seen with the wild-type promoter (Fig. 3 and
8). No promoter mutation functionally separated basal from
hormone-induced transcription, suggesting that all of the
trans-acting, DNA-binding transcription factors required for
basal transcription are also required for hormone-induced
transcription; stated in another way, hormone induction
does not render the MMTV promoter independent of any of
the DNA-binding transcription factors necessary for basal
transcription. Furthermore, since promoters with substan-
tially increased apparent affinity for NF-1 remained subject
to the same extent of hormone induction as the wild-type
promoter, facilitation or stabilization of NF-1 binding does
not appear to be a potential target for transcriptional activa-
tion of the MMTV promoter by steroid receptor proteins;
such a model has been suggested on the basis of detection of
NF-1 binding to the MMTV promoter in isolated nuclei only
when such nuclei are prepared from hormone-treated cells
(15).
Structure of the MMTV promoter. Promoters recognized
by RNA polymerase II generally have a modular structure
composed of a TATA element near position -30 and one or
more upstream elements whose position relative to the start
of transcription is not as rigidly constrained. The MMTV
promoter follows this basic pattern. Three distinct mutation-
sensitive regions (in addition to the sequences composing the
binding sites for the steroid hormone-receptor complexes)
were identified by our LS analysis and define the MMTV
promoter. One region contains a TATA element at the
expected position, a second contains as many as three
binding sites for proteins that recognize octamer-related
sequences, and a third contains a binding site for NF-1. It
will be of interest to determine how these basal promoter
elements, which by themselves direct a relatively low level
of transcription, are organized to allow the high degree of
modulation of transcriptional activity imposed by the HRE
and NRE.
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